89bioETNB

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

CEO
Mr. Rohan Palekar
5 / 53 reviews
100% recommend to a friend

$1.4B

Market Cap • 02/06/2023

2019

(4 years ago)
Founded

2019

(4 years ago)
IPO

San Francisco

Headquarters • California

45

Employees 2022

Valuation

Valuation Indicators
YearEquityRevenueEBITDAFin. Res.Net Inc.Net Mar.ROECashDebtN.D. / EBITDAOCFCAPEXFCFFreeDiv.
03/23 TTM4460-1020-105LL48125L-870439-870

The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.